$CW

Watts John C sold $166K of CW

Watts John C (EVP & Chief Growth Officer) sold 220 shares of CURTISS WRIGHT CORP (CW) at $752.91 ($0.17M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Watts John C
Published May 27, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CW
Neutral
high confidence
Mentioned
$CW
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CWNeutralLow
01

Why it matters

The newest fact is the specific sale: 220 shares at $752.91 totaling $165,640.20, executed on 2026-05-27 under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation and lack of fundamental updates make it low-signal for price action.

03

What to watch

The sale size is small relative to typical institutional flows, and the filing lacks context on total holdings, other grants, or whether future scheduled sales are larger.

Relevance 3/10Novelty 3/10Timing: Filed 2026-05-27, after-hours/late session disclosure window.

Background

The article is a primary-source SEC Form 4 insider transaction for Curtiss-Wright (CW).

Company-level read

Ticker impact

$CWNeutralHigh confidence
Context

Curtiss-Wright Form 4 shows EVP and Chief Growth Officer Watts sold 220 shares at $752.91 on 2026-05-27 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move driven by this filing alone.

Evidence & confidence

The disclosure is an open-market sale by an insider, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

Minimal, as the filing does not change guidance, contracts, or regulatory posture for the industrials/aerospace supply chain.

None indicated; this is company-specific insider transaction data.

None indicated; no cross-border deal or macro linkage is described.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with internal risk management or diversification, which some traders may interpret as mild negative sentiment.

Key entities

  • Curtiss-Wright Corp

    Subject of the Form 4 insider transaction disclosure.

  • Watts John C

    EVP and Chief Growth Officer who sold shares.

Related articles

$CWHighAI 9/10

Curtiss-Wright Q2 Earnings Call Highlights

Curtiss-Wright (NYSE:CW) reported Q2 commentary from its earnings call, citing a strengthening order book tied to U.S. and international defense spending and momentum in commercial aerospace and industrial markets. Defense Electronics sales fell 3% while Aerospace & Industrial and Naval & Power rose. The company raised 2026 guidance: sales +8% to +9%, operating margin 19.1% to 19.3%, diluted EPS $15.10 to $15.40, and record free cash flow $585M to $605M.

$CWMed

Curtiss-Wright Slides as Investors Weigh Strong Q2 Against Rich Expectations

Curtiss-Wright (CW) shares fell about 3.2% as investors weighed a strong Q2 against expectations. The company reported Q2 2026 sales of $924 million (+5%), adjusted operating margin of 19.4%, and adjusted EPS of $3.72, while raising full-year guidance to sales growth of 8% to 9% and adjusted EPS of $15.10 to $15.40. Orders were $1.1 billion (1.16 book-to-bill), but Defense Electronics revenue declined and Ground Defense fell 8% due to timing.

$CWHigh

CURTISS WRIGHT CORP (CW): Results of Operations and Financial Condition

CURTISS WRIGHT CORP (CW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_cwxq226xearnings.htm EX-99.1 Document Curtiss-Wright Corporation, Page 1 Exhibit 99.1 NEWS RELEASE CURTISS-WRIGHT REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE DAVIDSON, N.C. – August 5, 2026 – Curtiss-Wright Corporation (NYSE: C

$MSMed

Morgan Stanley stays bullish on aerospace, defense ahead of Q2 earnings By Investing.com

Ahead of Q2 earnings, Morgan Stanley kept a constructive view on aerospace and defense, citing resilient commercial demand, improving aircraft production, and durable aftermarket needs. It noted Boeing 737 MAX at 47 aircraft per month. For defense, it argued a $1.1T FY2027 base budget is underestimated. It downgraded Loar and TransDigm, cut CAE and Voyager, and adjusted price targets for multiple firms.